Dofetilide for the treatment of premature ventricular complexes and ventricular tachycardia in patients with structural heart disease.

Background: Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrial flutter. Given the efficacy of other class III agents, it has been used off‐label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). Ob...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Cardiovascular Electrophysiology Vol. 35; no. 12; pp. 2363 - 2372
Autores principales:	Deshmukh, Amrish, Yokokawa, Miki, McBride, Daniel, Simpson, Jamie, Chou, Andrew, Ghannam, Michael, Liang, Jackson J., Saeed, Mohammed, Cunnane, Ryan, Ghanbari, Hamid, Latchamsetty, Rakesh, Crawford, Thomas, Jongnarangsin, Krit, Pelosi, Frank, Chugh, Aman, Morady, Fred, Bogun, Frank, Oral, Hakan
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell Dec2024
Acceso en línea:	Ver este registro en EBSCOhost